Stockreport

TuHURA Biosciences Regains Compliance with Nasdaq Minimum Bid Price Requirement [Yahoo! Finance]

TuHURA Biosciences, Inc.  (HURA) 
PDF developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that on February 26, 2026, it received written notice from the Nasdaq Stock [Read more]